| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.047 | 0.5 |